Contact the Editorial Desk

Editorial correspondence

Gurl Peptide welcomes correspondence on the research record: a citation we have quoted inaccurately, a regulatory reference that has gone out of date, or a peer-reviewed study about PT-141, Kisspeptin or Melanotan II that should be added to the references page. Corrections that improve accuracy are the most useful messages we receive.

The most actionable notes specify three things: the page they refer to, the exact passage in question, and the supporting citation — a DOI or PubMed ID wherever possible. That lets us verify a proposed change against the source quickly.

Editorial mailbox: editors@gurlpeptide.com

What this desk cannot do

To be clear about what falls outside scope, Gurl Peptide is a literature digest — not a clinic, not a vendor, not a sexual-health counseling service. It cannot:

• Advise on, recommend, or comment on human use of any peptide discussed here.
• Suggest a dose, schedule, or route of administration for any individual.
• Comment on personal situations, symptoms, or clinical decisions.
• Sell, source, recommend, or help locate any compound from any supplier.
• Answer requests from athletes subject to anti-doping rules about these compounds, several of which fall under WADA's non-approved-substances framework.

Readers seeking clinical guidance should consult a licensed healthcare provider in their own jurisdiction. Responses to editorial correspondence are not guaranteed and may be delayed; the mailbox is monitored intermittently.